Cumberland Pharmaceuticals Inc
CPIX4.015USD
+0.495+14.06%
시장 운영 시간 （ET）시세는 15분 지연됩니다
60.07M시가총액
손실P/E TTM
자세한 내용은 Cumberland Pharmaceuticals Inc 회사
Cumberland Pharmaceuticals Inc. is a specialty pharmaceutical company. The Company is focused on the acquisition, development and commercialization of branded prescription pharmaceutical products. Its portfolio of brands includes Acetadote injection, for the treatment of acetaminophen poisoning; Caldolor injection, for the treatment of pain and fever, Kristalose for oral solution, a prescription laxative, for the treatment of constipation, and Omeclamox-Pak, oral, for the treatment of Helicobacter pylori infection and related duodenal ulcer disease. Its brands also include Sancuso transdermal, for the prevention of nausea and vomiting in patients receiving certain types of chemotherapy treatment; Vaprisol injection, to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia, and Vibativ injection for the treatment of certain serious bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia.
회사 정보
종목 코드 CPIX
회사 이름Cumberland Pharmaceuticals Inc
상장일Aug 11, 2009
CEOMr. A. J. Kazimi
직원 수91
유형Ordinary Share
회계 연도 종료Aug 11
주소1600 West End Avenue, Suite 1300
도시NASHVILLE
증권 거래소NASDAQ Global Select Consolidated
국가United States of America
우편 번호37203
전화18774842700
웹사이트https://www.cumberlandpharma.com/
종목 코드 CPIX
상장일Aug 11, 2009
CEOMr. A. J. Kazimi
회사 임원
이름
이름/직위
직위
주식 보유
변동
Mr. Kenneth J. Krogulski
Mr. Kenneth J. Krogulski
Independent Director
Independent Director
286.63K
+0.33%
Mr. James R. Jones
Mr. James R. Jones
Independent Director
Independent Director
43.34K
+0.39%
Ms. Caroline R. Young
Ms. Caroline R. Young
Independent Director
Independent Director
32.65K
+0.26%
Mr. John M. Hamm
Mr. John M. Hamm
Chief Financial Officer, Vice President
Chief Financial Officer, Vice President
20.07K
-22.81%
Mr. Todd M. Anthony
Mr. Todd M. Anthony
Vice President - Organizational Development
Vice President - Organizational Development
19.33K
+18.37%
Mr. Chris T. Bitterman
Mr. Chris T. Bitterman
Vice President - Sales and Marketing
Vice President - Sales and Marketing
6.68K
+42.71%
Mr. Martin S. Brown, Jr.
Mr. Martin S. Brown, Jr.
Director
Director
--
--
Dr. Gordon R. Bernard, M.D.
Dr. Gordon R. Bernard, M.D.
Independent Director
Independent Director
--
--
Mr. A. J. Kazimi
Mr. A. J. Kazimi
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
--
--
Mr. Joseph C. Galante
Mr. Joseph C. Galante
Independent Director
Independent Director
--
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Kenneth J. Krogulski
Mr. Kenneth J. Krogulski
Independent Director
Independent Director
286.63K
+0.33%
Mr. James R. Jones
Mr. James R. Jones
Independent Director
Independent Director
43.34K
+0.39%
Ms. Caroline R. Young
Ms. Caroline R. Young
Independent Director
Independent Director
32.65K
+0.26%
Mr. John M. Hamm
Mr. John M. Hamm
Chief Financial Officer, Vice President
Chief Financial Officer, Vice President
20.07K
-22.81%
Mr. Todd M. Anthony
Mr. Todd M. Anthony
Vice President - Organizational Development
Vice President - Organizational Development
19.33K
+18.37%
Mr. Chris T. Bitterman
Mr. Chris T. Bitterman
Vice President - Sales and Marketing
Vice President - Sales and Marketing
6.68K
+42.71%
수익 분석
통화: USD마지막 업데이트: Sun, Jul 6
통화: USD마지막 업데이트: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
사업별USD
이름
수익
비율
Kristalose
3.48M
29.75%
Other
3.14M
26.82%
Sancuso
2.26M
19.26%
Vibativ
1.38M
11.77%
Caldolor
1.31M
11.16%
Other
145.32K
1.24%
데이터 없음
사업별
지역별
사업별USD
이름
수익
비율
Kristalose
3.48M
29.75%
Other
3.14M
26.82%
Sancuso
2.26M
19.26%
Vibativ
1.38M
11.77%
Caldolor
1.31M
11.16%
Other
145.32K
1.24%
주식 보유 통계
마지막 업데이트: Sat, May 17
마지막 업데이트: Sat, May 17
주주
주주 유형
주주
주주
비율
Kazimi (A J)
38.09%
Millennium Management LLC
5.41%
Ikarian Capital LLC
4.95%
Renaissance Technologies LLC
3.36%
The Vanguard Group, Inc.
2.78%
Other
45.40%
주주
주주
비율
Kazimi (A J)
38.09%
Millennium Management LLC
5.41%
Ikarian Capital LLC
4.95%
Renaissance Technologies LLC
3.36%
The Vanguard Group, Inc.
2.78%
Other
45.40%
주주 유형
주주
비율
Individual Investor
41.55%
Hedge Fund
17.27%
Investment Advisor/Hedge Fund
6.65%
Investment Advisor
4.64%
Research Firm
0.20%
Other
29.69%
기관 주식 보유
마지막 업데이트: Tue, Jul 1
마지막 업데이트: Tue, Jul 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q2
58
10.52M
70.31%
+1.09M
2025Q1
59
10.52M
73.16%
+1.08M
2024Q4
52
8.07M
57.45%
-343.10K
2024Q3
52
8.34M
59.24%
-180.73K
2024Q2
52
8.35M
58.98%
-447.58K
2024Q1
57
8.44M
59.58%
-449.08K
2023Q4
62
8.78M
62.03%
-467.34K
2023Q3
65
8.77M
61.54%
-560.49K
2023Q2
70
8.94M
62.04%
-503.74K
2023Q1
68
8.99M
62.25%
-489.70K
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Kazimi (A J)
5.70M
38.09%
+168.00
+0.00%
May 30, 2025
Millennium Management LLC
809.90K
5.41%
-419.74K
-34.14%
Mar 31, 2025
Ikarian Capital LLC
740.00K
4.95%
+740.00K
--
Mar 31, 2025
Renaissance Technologies LLC
503.36K
3.36%
-3.80K
-0.75%
Mar 31, 2025
The Vanguard Group, Inc.
416.57K
2.78%
+42.32K
+11.31%
Mar 31, 2025
Krogulski (Kenneth J)
285.70K
1.91%
+945.00
+0.33%
May 30, 2025
Dimensional Fund Advisors, L.P.
252.19K
1.69%
-20.78K
-7.61%
Mar 31, 2025
J. Goldman & Co., L.P.
241.48K
1.61%
+241.48K
--
Mar 31, 2025
Boothbay Fund Management, LLC
223.80K
1.5%
+223.80K
--
Mar 31, 2025
Bridgeway Capital Management, LLC
184.16K
1.23%
--
--
Mar 31, 2025
더 보기
관련 ETF
마지막 업데이트: Sat, Aug 2
마지막 업데이트: Sat, Aug 2
이름
비율
iShares Micro-Cap ETF
0.01%
iShares Core S&P Total U.S. Stock Market ETF
0%
Dimensional US Core Equity 1 ETF
0%
Avantis US Small Cap Equity ETF
0%
iShares Micro-Cap ETF
비율0.01%
iShares Core S&P Total U.S. Stock Market ETF
비율0%
Dimensional US Core Equity 1 ETF
비율0%
Avantis US Small Cap Equity ETF
비율0%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
유형
비율
데이터 없음
날짜
유형
비율
데이터 없음
